Benzinga | Nov 10, 2020 04:25PM EST

Exagen Q3 EPS $(0.34) Beats $(0.48) Estimate, Sales $10.80M Beat $8.88M Estimate

Exagen (NASDAQ:XGN) reported quarterly losses of $(0.34) per share which beat the analyst consensus estimate of $(0.48) by 29.17 percent. This is a 83.65 percent increase over losses of $(2.08) per share from the same period last year. The company reported quarterly sales of $10.80 million which beat the analyst consensus estimate of $8.88 million by 21.62 percent. This is a 3.46 percent increase over sales of $10.44 million the same period last year.